Old Web
English
Sign In
Acemap
>
Paper
>
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
2017
Andrew McGarry
Michael P. McDermott
Karl Kieburtz
Elisabeth A. de Blieck
Flint Beal
Karen Marder
Christopher A. Ross
Ira Shoulson
Peter Gibert
William M. Mallonee
Mark Guttman
Joanne Wojcieszek
Rajeev Kumar
Mark S. LeDoux
Mary E. Jenkins
H. Diana Rosas
Martha Nance
Kevin M. Biglan
Peter Como
Richard Dubinsky
Kathleen M. Shannon
Padraig O'Suilleabhain
Kelvin L. Chou
Francis O. Walker
Wayne Martin
Vicki Wheelock
Elizabeth McCusker
Joseph Jankovic
Carlos Singer
Juan Sanchez-Ramos
Burton L. Scott
Oksana Suchowersky
Stewart A. Factor
Donald S. Higgins
Eric Molho
Fredy J. Revilla
John Nathaniel Caviness
Joseph H. Friedman
Joel S. Perlmutter
Andrew Feigin
Karen E. Anderson
Ramon L. Rodriguez
Nikolaus R. McFarland
Russell L. Margolis
Eric S. Farbman
Lynn A. Raymond
Valerie Suski
Sandra K. Kostyk
Amy Colcher
Lauren Seeberger
Eric A. Epping
Sherali Esmail
Nancy Diaz
Wai Lun Alan Fung
Alan Diamond
Samuel Frank
Philip C. Hanna
Neal Hermanowicz
Leon S. Dure
Merit Cudkowicz
Keywords:
Coenzyme Q10
Physical therapy
Disease
Placebo-controlled study
Medicine
Internal medicine
double blind
Gastroenterology
functional decline
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
28
Citations
NaN
KQI
[]